Tenet Healthcare (NYSE:THC) Upgraded at StockNews.com

StockNews.com upgraded shares of Tenet Healthcare (NYSE:THCFree Report) from a hold rating to a buy rating in a report issued on Thursday.

Several other brokerages also recently issued reports on THC. KeyCorp reduced their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Truist Financial decreased their price target on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Barclays cut their price objective on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a report on Thursday, February 13th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $177.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 13th. Finally, Raymond James cut shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective on the stock. in a research note on Friday, November 22nd. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $163.88.

Read Our Latest Analysis on Tenet Healthcare

Tenet Healthcare Price Performance

THC opened at $122.76 on Thursday. Tenet Healthcare has a 1 year low of $90.03 and a 1 year high of $171.20. The company’s 50 day simple moving average is $132.46 and its 200 day simple moving average is $144.62. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. The stock has a market capitalization of $11.68 billion, a PE ratio of 3.81, a P/E/G ratio of 1.02 and a beta of 2.06.

Tenet Healthcare (NYSE:THCGet Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. As a group, sell-side analysts expect that Tenet Healthcare will post 12.24 EPS for the current year.

Insiders Place Their Bets

In related news, Director J Robert Kerrey sold 9,525 shares of the company’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares of the company’s stock, valued at approximately $3,434,022.54. This represents a 25.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.93% of the company’s stock.

Institutional Trading of Tenet Healthcare

A number of hedge funds have recently bought and sold shares of THC. Assetmark Inc. raised its stake in shares of Tenet Healthcare by 190.3% in the 3rd quarter. Assetmark Inc. now owns 5,446 shares of the company’s stock valued at $905,000 after buying an additional 3,570 shares in the last quarter. Atria Investments Inc raised its stake in shares of Tenet Healthcare by 31.8% in the 3rd quarter. Atria Investments Inc now owns 3,871 shares of the company’s stock valued at $643,000 after buying an additional 935 shares in the last quarter. Sigma Planning Corp acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at $605,000. Crossmark Global Holdings Inc. raised its stake in shares of Tenet Healthcare by 34.9% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 6,187 shares of the company’s stock valued at $1,028,000 after buying an additional 1,600 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its stake in shares of Tenet Healthcare by 36.0% in the 3rd quarter. Venturi Wealth Management LLC now owns 521 shares of the company’s stock valued at $87,000 after buying an additional 138 shares in the last quarter. 95.44% of the stock is owned by institutional investors.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Read More

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.